Sartorius confirms full-year targets after Q1 growth

Sartorius has published its financial results for the first quarter of 2013, during which it experienced a 4.2 percent year-on-year increase in sales revenue.

This brought the firm's revenue total for the period to 214.3 million euros (181.2 million pounds), while order intake increased by 10.1 percent and profit rose by 8.4 percent during the quarter.

Growth momentum for Sartorius' bioprocess solutions division was shown to be particularly robust, giving the company strong confidence in this unit's further prospects, although volatile trading conditions created an impact on its industrial weighing and lab products and services divisions.

However, at a group level Sartorius remains completely on course in terms of its sales revenue and profit development momentum.

Chief executive officer Dr Joachim Kreuzburg said: "We expect to reach our full-year targets for the group."

The company's Sartorius Stedim Biotech division also achieved a strong performance during Q1 2013, with double-digit growth in order intake observed.